Karen Meehan
Adult Health · Chicago, ILNPI 1972837037
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,651 of the $8,088 with a category attached, or 69.9%. 14 manufacturers reported payments, led by Abbott at 57.5% of the total. Reporting peaked in 2024 at $3,986 and has fallen 88.4% since, to $462 in 2025. Among adult health clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 134 payments — averaging $60.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Medtronic$2K
- Abiomed$370
- Edwards Lifesciences$151
- Cvrx, Inc.$135
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$102
- plus $263 from 8 others
What the payments were for
- Travel & lodging$2,40730%
- Food & beverage$5,65170%
- Entertainment$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 76 | $4,649 |
| Medtronic | 31 | $2,419 |
| Abiomed | 4 | $370 |
| Edwards Lifesciences | 5 | $151 |
| Cvrx, Inc. | 1 | $135 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $102 |
| AstraZeneca | 4 | $68 |
| Pfizer | 2 | $40 |
| Merck | 2 | $36 |
| Argentum Medical | 1 | $30 |
| Novartis | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$2,269
- CARDIOMEMS$396
- Impella$284
- 2ND GEN CENTRIMAG PRIMARY CONSOLE$183
- HVAD PUMP IMPLANT KIT$150
- HeartMate 3 Left Ventricular Assist Device$139
- Barostim Neo System$135
How this compares
$8,088 in reported general payments places this provider in the 95th percentile of 553 adult health providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 15 | $12,431 |
| FarxigaDapagliflozin Propanediol | 14 | $10,124 |
| Digoxin | 19 | $453 |
| Potassium Chloride | 20 | $427 |
| Warfarin Sodium | 50 | $342 |
| Spironolactone | 53 | $250 |
| Amiodarone Hcl | 11 | $208 |
| Metoprolol Succinate | 25 | $197 |
| Cephalexin | 17 | $158 |
| Atorvastatin Calcium | 24 | $118 |
| Lisinopril | 16 | $80 |
| Furosemide | 19 | $67 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $25 | $12,43115 claims |
| AstraZenecaFarxiga | $68 | $10,12414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 553 adult health providers in Illinois.
Other adult health in Chicago
- Colleen FolkersChicago$86K
- Matthew BurkeChicago$44K
- Jacklyn GideonChicago$38K
- Jennifer GreenfieldChicago$35K
- Tammy PomaChicago$32K
- Cecille CruzChicago$15K
- Margaret SchwartzChicago$14K
- Michelle EversChicago$8K
- Keriann KordasChicago$5K
- Jessica CharronChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.